The roles of CHAD and UGT2A3 in IBD pathogenesis remain less characterized, with CHAD functions primarily established in bone metabolism and cell-cell adhesion (28) (29), while UGT2A3 research has focused on cancer and drug metabolism (30, 31), leaving their IBD-specific contributions largely unexplored. Here, UGT2A3 is linked to cancer.